Evidence map›Paper›PMID 33875584›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Human retroviral antisense mRNAs are retained in the nuclei of infected cells for viral persistence.

Guangyong Ma, Jun-Ichirou Yasunaga, Kazuya Shimura, Keiko Takemoto, Miho Watanabe, Masayuki Amano, Hirotomo Nakata, Benquan Liu, Xiaorui Zuo, Masao Matsuoka

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Identification of AK4 and RHOC as potential oncogenes addicted by adult T cell leukemia.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Guangyong MaInstitute of Pharmaceutical Science, China Pharmaceutical University, Nanjing 210009, China; gma@cpu.edu.cn mamatsu@kumamoto-u.ac.jp.ORCID 0000-0002-2003-7201
Jun-Ichirou YasunagaInstitute for Frontier Life and Medical Sciences, Kyoto University, Kyoto 606-8507, Japan.ORCID 0000-0002-7939-2080
Kazuya ShimuraInstitute for Frontier Life and Medical Sciences, Kyoto University, Kyoto 606-8507, Japan.
Keiko TakemotoInstitute for Frontier Life and Medical Sciences, Kyoto University, Kyoto 606-8507, Japan.
Miho WatanabeDepartment of Hematology, Rheumatology and Infectious Diseases, Kumamoto University School of Medicine, Kumamoto 860-8556, Japan.
Masayuki AmanoDepartment of Hematology, Rheumatology and Infectious Diseases, Kumamoto University School of Medicine, Kumamoto 860-8556, Japan.ORCID 0000-0003-0516-9502
Hirotomo NakataDepartment of Hematology, Rheumatology and Infectious Diseases, Kumamoto University School of Medicine, Kumamoto 860-8556, Japan.
Benquan LiuInstitute of Pharmaceutical Science, China Pharmaceutical University, Nanjing 210009, China.
Xiaorui ZuoInstitute of Pharmaceutical Science, China Pharmaceutical University, Nanjing 210009, China.
Masao MatsuokaInstitute for Frontier Life and Medical Sciences, Kyoto University, Kyoto 606-8507, Japan; gma@cpu.edu.cn mamatsu@kumamoto-u.ac.jp.ORCID 0000-0002-0473-754X
Kyoto University · JPChina Pharmaceutical University · CNKumamoto University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human retroviruses, including human T cell leukemia virus type 1 (HTLV-1) and HIV type 1 (HIV-1), encode an antisense gene in the negative strand of the provirus. Besides coding for proteins, the messenger RNAs (mRNAs) of retroviral antisense genes have also been found to regulate transcription directly. Thus, it has been proposed that retroviruses likely localize their antisense mRNAs to the nucleus in order to regulate nuclear events; however, this opposes the coding function of retroviral antisense mRNAs that requires a cytoplasmic localization for protein translation. Here, we provide direct evidence that retroviral antisense mRNAs are localized predominantly in the nuclei of infected cells. The retroviral 3' LTR induces inefficient polyadenylation and nuclear retention of antisense mRNA. We further reveal that retroviral antisense RNAs retained in the nucleus associate with chromatin and have transcriptional regulatory function. While HTLV-1 antisense mRNA is recruited to the promoter of C-C chemokine receptor type 4 (

Indexed as

Basic-Leucine Zipper Transcription FactorsCell LineCell NucleusGene ExpressionGene Expression Regulation, ViralHIV-1Human Immunodeficiency Virus ProteinsHumansHuman T-lymphotropic virus 1Primary Cell CulturePromoter Regions, GeneticProvirusesRetroviridae ProteinsRNA, AntisenseRNA, MessengerRNA, ViralASP protein, HIV-1Basic-Leucine Zipper Transcription FactorsHBZ protein, human T-cell leukemia virus type IHuman Immunodeficiency Virus ProteinsRetroviridae ProteinsRNA, AntisenseRNA, MessengerRNA, ViralViral Envelope ProteinsViral ProteinsASPHBZHIV-1HTLV-1RNA-FISH

Identifiers

PMID33875584
PMCPMC8092383
OpenAlexW3155398660

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.